公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2010 | Extended O6-Methylguanine methyltransferase promoter hypermethylation following n-butylidenephthalide combined with 1, 3-Bis(2-chloroethyl)-1-nitrosourea (BCNU) on inhibition of human hepatocellular carcinoma cell growth | Yu Y.-L.; SUNG-LIANG YU ; Su K.-J.; Wei C.-W.; Jian M.-H.; Lin P.-C.; Tseng I.-H.; Lin C.-C.; Su C.-C.; Chan D.-C.; Lin S.-Z.; Harn H.-J.; Chen Y.-L.S. | Journal of Agricultural and Food Chemistry | 26 | 27 | |
2019 | Extracorporeal Life Support Enhances the Forward Pressure Wave to Cause a Mismatch between Cardiac Oxygen Demand and Supply | CHIH-HSIEN WANG ; Chang, Ru-Wen; EN-TING WU ; Hsiao, Yi-Jing; MING-SHIOU WU ; HSI-YU YU ; YIH-SHARNG CHEN ; LIANG-CHUAN LAI ; SUNG-LIANG YU | Scientific reports | 1 | 0 | |
2018 | FAM198B is associated with prolonged survival and inhibits metastasis in lung adenocarcinoma via blockage of ERK-Mediated MMP-1 expression | Hsu C.-Y.; Chang G.-C.; Chen Y.-J.; Hsu Y.-C.; Hsiao Y.-J.; KANG-YI SU ; Chen H.-Y.; Lin C.-Y.; JIN-SHING CHEN ; Chen Y.-J.; Hong Q.-S.; Ku W.-H.; Wu C.-Y.; Ho B.-C.; Chiang C.-C.; PAN-CHYR YANG ; SUNG-LIANG YU | Clinical Cancer Research | 20 | 20 | |
2010 | A feeder-free culture using autogeneic conditioned medium for undifferentiated growth of human embryonic stem cells: Comparative expression profiles of mRNAs, microRNAs and proteins among different feeders and conditioned media | Tsai Z.-Y.; Singh S.; SUNG-LIANG YU ; Chou C.-H.; Li S.S. | BMC Cell Biology | 16 | 9 | |
2007 | A five-gene signature and clinical outcome in non-small-cell lung cancer | Chen H.-Y.; SUNG-LIANG YU ; Chen C.-H.; Chang G.-C.; Chen C.-Y.; ANG YUAN ; Cheng C.-L.; Wang C.-H.; Terng H.-J.; Kao S.-F.; Chan W.-K.; Li H.-N.; Liu C.-C.; Singh S.; WEI J. CHEN ; Chen J.J.W.; PAN-CHYR YANG | New England Journal of Medicine | 798 | 735 | |
2013 | Focal amplification of HOXD-harboring chromosome region is implicated in multiple-walled carbon nanotubes-induced carcinogenicity | Wu P.; Yuan S.-S.; CHAO-CHI HO ; Hsieh W.-Y.; Hong Q.-S.; SUNG-LIANG YU ; Chen W.; Chen H.-Y.; Wang C.-D.; Li K.-C.; PAN-CHYR YANG ; HUEI-WEN CHEN | Nano Letters | 12 | 11 | |
2009 | A four-gene signature from NCI-60 cell line for survival prediction in non-small cell lung cancer | Hsu Y.-C.; Yuan S.-S.; Chen H.-Y.; SUNG-LIANG YU ; Liu C.-H.; Hsu P.-Y.; Wu G.; Lin C.-H.; Chang G.-C.; Li K.-C.; PAN-CHYR YANG | Clinical Cancer Research | 47 | 43 | |
2020 | FPGS relapse-specific mutations in relapsed childhood acute lymphoblastic leukemia | SUNG-LIANG YU ; Zhang, Hui; Ho, Bing-Ching; Yu, Chih-Hsiang; Chang, Chia-Ching; Hsu, Yin-Chen; Ni, Yu-Ling; Lin, Kai-Hsin; SHIANN-TANG JOU ; MENG-YAO LU ; Chen, Shu-Huey; Wu, Kang-Hsi; Wang, Shih-Chung; HSIU-HAO CHANG ; Pui, Ching-Hon; Yang, Jun J; Zhang, Jinghui; Lin, Dong-Tsamn; SHU-WHA LIN ; Ma, Xiaotu; YUNG-LI YANG | Scientific Reports | 7 | 6 | |
2012 | Galectin-1 promotes lung cancer progression and chemoresistance by upregulating p38 MAPK, ERK, and cyclooxygenase-2 | Chung L.-Y.; Tang S.-J.; Sun G.-H.; Chou T.-Y.; Yeh T.-S.; SUNG-LIANG YU ; Sun K.-H. | Clinical Cancer Research | 127 | 122 | |
2017 | Gene expression of MAGE-A3 and PRAME tumor antigens and EGFR mutational status in Taiwanese non–small cell lung cancer patients | SZU-HUA PAN ; KANG-YI SU ; Spiessens B.; Kusuma N.; Delahaye N.F.; Gruselle O.; Myo A.; de Creus A.; Louahed J.; Chang G.-C.; SUNG-LIANG YU ; PAN-CHYR YANG | Asia-Pacific Journal of Clinical Oncology | 14 | 14 | |
2005 | Gene expression profiles in hypoxic preconditioning using cDNA microarray analysis: Altered expression of an angiogenic factor, carcinoembryonic antigen-related cell adhesion molecule 1 | WEN-JONE CHEN ; HUEI-WEN CHEN ; SUNG-LIANG YU ; CHIEN-HUA HUANG ; TZUNG-DAU WANG ; Chen J.J.W.; Chien C.-T.; Chen H.-Y.; PAN-CHYR YANG ; Lee Y.-T. | Shock | 40 | 37 | |
2013 | Genome-wide analysis of three-way interplay among gene expression, cancer cell invasion and anti-cancer compound sensitivity | Hsu Y.-C.; Chen H.-Y.; Yuan S.; SUNG-LIANG YU ; Lin C.-H.; Wu G.; PAN-CHYR YANG ; Li K.-C. | BMC Medicine | 30 | 31 | |
2021 | Genome-wide epigenetic landscape of lung adenocarcinoma links HOXB9 DNA methylation to intrinsic EGFR-TKI resistance and heterogeneous responses | SU, SHENG-FANG ; Liu, Chia-Hsin; Cheng, Chiou-Ling; CHAO-CHI HO ; Yang, Tsung-Ying; Chen, Kun-Chieh; Hsu, Kuo-Hsuan; Tseng, Jeng-Sen; HUEI-WEN CHEN ; Chang, Gee-Chen; SUNG-LIANG YU ; Li, Ker-Chau | JCO Precision Oncology | 9 | 6 | |
2018 | Genome-Wide Scan for Copy Number Alteration Association with Relapse-Free Survival in Colorectal Cancer with Liver Metastasis Patients | Yang, Po-Sheng; Hsu, Hsi-Hsien; Hsu, Tzu-Chi; Chen, Ming-Jen; Wang, Cin-Di; SUNG-LIANG YU ; Hsu, Yi-Chiung; Li, Ker-Chau | Journal of clinical medicine | 9 | 9 | |
2019 | High PD-L1 expression correlates with primary resistance to EGFR-TKIs in treatment naïve advanced EGFR-mutant lung adenocarcinoma patients | Hsu K.-H.; Huang Y.-H.; Tseng J.-S.; Chen K.-C.; Ku W.-H.; KANG-YI SU ; Chen J.J.W.; HUEI-WEN CHEN ; SUNG-LIANG YU ; Yang T.-Y.; Chang G.-C. | Lung Cancer | 64 | 52 | |
2016 | Higher frequency but random distribution of EGFR mutation subtypes in familial lung cancer patients | Hsu K.-H.; Tseng J.-S.; Wang C.-L.; Yang T.-Y.; Tseng C.-H.; Chen H.-Y.; Chen K.-C.; Tsai C.-R.; Yang C.-T.; SUNG-LIANG YU ; KANG-YI SU ; CHONG-JEN YU ; CHAO-CHI HO ; Hsia T.-C.; Wu M.-F.; Chiu K.-L.; Liu C.-M.; PAN-CHYR YANG ; Chen J.J.W.; Chang G.-C. | Oncotarget | 9 | 9 | |
2022 | HLJ1 amplifies endotoxin-induced sepsis severity by promoting IL-12 heterodimerization in macrophages | Luo, Wei-Jia; SUNG-LIANG YU ; Chang, Chia-Ching; Chien, Min-Hui; Chang, Ya-Ling; Liao, Keng-Mao; Lin, Pei-Chun; KUEI-PIN CHUNG ; YA-HUI CHUANG ; Chen, Jeremy J W; PAN-CHYR YANG ; KANG-YI SU | eLife | 7 | 3 | |
2010 | HLJ1 is a novel caspase-3 substrate and its expression enhances UV-induced apoptosis in non-small cell lung carcinoma | Lin S.-Y.; Hsueh C.-M.; SUNG-LIANG YU ; Su C.-C.; Shum W.-Y.; Yeh K.-C.; Chang G.-C.; Chen J.J.W. | Nucleic Acids Research | 28 | 25 | |
2016 | HLJ1 is an endogenous Src inhibitor suppressing cancer progression through dual mechanisms | Chen C.-H.; Chang W.-H.; KANG-YI SU ; Ku W.-H.; Chang G.-C.; Hong Q.-S.; Hsiao Y.-J.; Chen H.-C.; Chen H.-Y.; Wu R.; PAN-CHYR YANG ; Chen J.J.W.; SUNG-LIANG YU | Oncogene | 21 | 21 | |
2013 | The HLJ1-targeting drug screening identified Chinese herb andrographolide that can: Suppress tumour growth and invasion in non-small-cell lung cancer | Lai Y.-H.; SUNG-LIANG YU ; Chen H.-Y.; Wang C.-C.; HUEI-WEN CHEN ; Chen J.J. | Carcinogenesis | 40 | 36 | |